August 3, 2021
Genetic Engineering & Biotechnology News (GEN)
“FDNA, a digital health company, It develops AI technologies and software as a service (SaaS) platforms that are used by thousands of clinical and research laboratories globally to aid in the early detection of rare genetic diseases. The company’s database of phenotypic information is exceptionally large, covering more than 5,000 syndromes. All of this information is accessible via cloud computing.”
The article from GenEngNews.com describes that FDNA is at the forefront of transforming genomic data into actionable insights using AI technology. FDNA’s innovative tool, Face2Gene, employs advanced AI algorithms to analyze facial features and integrate genomic data, identifying genetic disorders with high precision. By comparing patient photos to a vast database of known genetic conditions, Face2Gene provides rapid and accurate diagnostic insights. FDNA’s technology significantly enhances the clinical utility of genomic data, enabling earlier diagnoses and personalized treatment plans. This breakthrough demonstrates the powerful potential of AI in making genomic data actionable, ultimately improving outcomes for patients with genetic disorders.
